Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics, cytokine inhibitory drugs; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for use in immunotherapies; pharmaceutical preparations for use in T-cell immunotherapy; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for human use namely T-cells for medical purposes; pharmaceutical preparations for human use namely diagnostic kits consisting primarily of cells for medical laboratory use; Pharmaceutical preparations for human use for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use namely antivirals for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for human use namely monoclonal antibodies.

Ingredients for use in the manufacture of pharmaceuticals; ingredients for use in the manufacture of drugs; pharmaceuticals; drugs.

Wholesale store services for pharmaceuticals and drugs.

Enterprise resource planning [erp] software for the purpose of content management, rights management, metadata management and programming/scheduling for television, radio, film, audiovisual and telecommunications companies; cms [content management system] software for controlling and managing access server applications; broadcasting equipment, namely transmitters and receivers apparatus namely television receivers and transmitters, cable television transmitters and radio receivers and transmitters for radio broadcasting, television broadcasting and remote transmission; information technology and audio-visual, multimedia and photographic devices, namely, multimedia projectors; computer data storage devices, namely, high-speed storage subsystems for storage and backup of electronic data either locally or via a telecommunications network; application software for data communication and translating and transmitting data sold therewith; computer multimedia software for the integration of text, audio, graphics, still images, and moving pictures; computer application software for broadcasting sound and video; computer application software for operating and controlling smart TVs; electronic recorded content and media content, namely, electronic data files featuring text, graphics and images in the field of telecommunications technology; media software, namely, computer software applications for data communication and translating and transmitting data sold therewith; devices for streaming video and media content namely televisions, computers, tablets and mobile phones; digital recording media, namely, pre-recorded DVDs, downloadable audio and video recordings, and CDs featuring and promoting texts, graphics and images in the field of telecommunications technology; audio devices, namely audio receivers, audio recorders, audio transmitter units and radio receivers; data transmitting apparatus, namely, transmitting and receiving apparatus for radio and television broadcasting and for long-distance transmission; display devices, namely display monitors, television receivers and film and video devices in the nature of video recorders and cameras; computer software for media storage, broadcasting and streaming, namely, computer software applications for data communication and translating and transmitting data sold therewith; computer software to enhance the audio-visual capabilities of multimedia applications and for the integration of text, audio, graphics, still images and moving pictures; portable multimedia players, namely smartphones, MP3s, DVD players; downloadable interactive multimedia computer programs for aggregating and playing multimedia content; computer software for streaming videos from digital media content sessions; computer software for the development of media editing, formatting and manipulating the media data; downloadable and cloud hosted computer application software for streaming audio-visual media content via the Internet; media players, namely handheld computers, MP3s, DVD players, CD players; data storage devices being magnetic tapes, data storage media namely blank USB flash drives, blank CDS, blank DVDs; video display terminals; telephone terminals; network management software; industrial process control software; computer software for workflow management systems for use in the broadcasting, media and telecom industry; downloadable computer software for daily tasks management in the field of workflow management; computer software for managing and scheduling media content for linear TV, Video on Demand, streaming platforms, OTT and FAST TV; desktop publishing software; computer programming software making use of artificial intelligence and machine learning in the field of big data for business data analytics and user behavior analytics; document management system software; computer hardware

Implementation services for the implementation of application software and technical and functional support services namely, troubleshooting in the nature of diagnosing computer hardware, cloud infrastructure and software problems; technical support services, namely, monitoring of technological functions of computer network systems used in the design and development of database applications, in the processing and management of information, and in electronic communications involved in the arranging of business transactions to ensure proper functioning; software development; software programming; software implementation; software design; software design engineering; development of interactive multimedia software; computer code conversion for others; electronic storage of digital music, audiovisual content, television broadcasts, podcasts, electronic digitizing of photographs into a computer readable media; rental of software for importing and managing data; design and development of software for importing and managing data; hosting of multimedia applications; hosting of software applications in the field of the broadcasting, audiovisual and telecom industry; hosting of websites related to media content, computer and video games, music and video streaming; computer programming of multimedia equipment services; computer software programming of software for internet platforms services; hosting of audiovisual content, namely digital music, television broadcast, streaming platforms, photographs, podcasts; hosting websites on the internet; cross-platform conversion of digital content into other forms of digital content

Entertainment in the form of math competitions; entertainment services in the nature of live theatrical performances; language training services; mobile library services; online video gaming services; providing amusement parks; providing gymnastic facilities; providing zip line rides for recreational purposes; publication of books; video arcade services

Blockchain network operating software; computer application software for blockchain-based platforms, namely software platforms for using a consensus engine incorporating blockchain technology for securing data with cryptographic information; computer software for setting up and configuring blockchain networks; computer software platforms for developing, building and managing the running of distributed software applications

Think tank services, namely consultation services in the field of business management and in the field of business process improvement through the use of emerging technologies, namely blockchain technologies, cognitive computing, machine learning and predictive analytics

Advertising, marketing and public relations; organization of exhibitions and trade fairs for commercial or advertising purposes; development of advertising concepts; provision of an online marketplace for buyers and sellers of goods and services.

Land, water and air transport services; rental of land, water or air vehicles; arranging of tours; travel reservation; issuing of tickets for travel; courier services (messages or merchandise).

Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics, cytokine inhibitory drugs; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for use in immunotherapies; pharmaceutical preparations for use in T-cell immunotherapy; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for human use namely T-cells for medical purposes; pharmaceutical preparations for human use namely diagnostic kits consisting primarily of cells for medical laboratory use; Pharmaceutical preparations for human use for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use namely antivirals for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for human use namely monoclonal antibodies.

Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics, cytokine inhibitory drugs; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for use in immunotherapies; pharmaceutical preparations for use in T-cell immunotherapy; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for human use namely T-cells for medical purposes; pharmaceutical preparations for human use namely diagnostic kits consisting primarily of cells for medical laboratory use; Pharmaceutical preparations for human use for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use namely antivirals for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for human use namely monoclonal antibodies.

Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics, cytokine inhibitory drugs; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for use in immunotherapies; pharmaceutical preparations for use in T-cell immunotherapy; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for human use namely T-cells for medical purposes; pharmaceutical preparations for human use namely diagnostic kits consisting primarily of cells for medical laboratory use; Pharmaceutical preparations for human use for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use namely antivirals for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for human use namely monoclonal antibodies.

Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics, cytokine inhibitory drugs; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for use in immunotherapies; pharmaceutical preparations for use in T-cell immunotherapy; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for human use namely T-cells for medical purposes; pharmaceutical preparations for human use namely diagnostic kits consisting primarily of cells for medical laboratory use; Pharmaceutical preparations for human use for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use namely antivirals for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for human use namely monoclonal antibodies.